Journal of Lipids

Research Article

Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19

Table 2

Demographic, hematological, lipid profile and its relative ratios of COVID-19 in survivor and nonsurvivor patients.
VariablesCOVID-19 value
Survival ()Death ()
Age≤0.001
Sex0.837
 Male, (%)16 (9.1)
 Female, (%)10 (8.1)
Hospitalization stay≤0.001
WBC (×109/L)≤0.001
Neutrophil (×109/L)0.562
Lymphocyte (×109/L)≤0.001
Monocyte (×109/L)0.172
Hb (mg/mL)0.092
Hct (%)0.120
PLT (×109/L)0.192
PT (s)0.256
PTT0.570
INR0.510
ALT (IU/L)≤0.05
AST (IU/L)≤0.05
LDH (IU/L)0.499
Ferritin (μg/L)≤0.05
ESR (mm/hr)0.777
FBG (mg/mL)≤0.001
Urea (mg/mL)≤0.001
Cr (mg/mL)≤0.05
D.dimer (mg/L)0.055
ALP (IU/L)≤0.01
Na (mEq/L)0.284
K (mEq/L)0.065
TC (mg/mL)≤0.001
TC adjusted≤0.001
TG (mg/mL)≤0.05
TG adjusted (mg/mL)≤0.001
LDL-C (mg/mL)0.104
LDL-C adjusted (mg/mL)≤0.001
HDL-C (mg/mL)0.902
HDL-C adjusted (mg/mL)≤0.001
TC/HDL-C≤0.001
TG/HDL-C≤0.001
LDL-C/HDL-C≤0.001
WBC/HDL-C≤0.001
NT/HDL-C0.148
LM/HDL-C≤0.001
MN/HDL-C0.205
FBG/HDL-C≤0.001
Severity≤0.001
 Moderate, (%)224 (99.6)1 (0.4)
 Severe, (%)49 (80.3)12 (19.7)
 Very severe, (%)1 (7.1)13 (92.9)
Comorbidities
 Cardiovascular disease (%)18.665.4≤0.001
 Respiratory disease (%)13.130.8≤0.05
 Kidney disease (%)6.923.1≤0.05
 Diabetes (%)22.657.7≤0.001
 Cancer (%)4.015.4≤0.05
 Liver (%)2.93.80.563
Abbreviations are similar to those of Table 1.